Loading...
Frontpage2024-11-08T14:40:53+01:00

The aim of the EuroSpA Research Collaboration Network

The aim of the EuroSpA Research Collaboration Network (RCN) is to jointly address research questions in SpA including, but not limited to, real world effectiveness and safety profiles of biologic therapies. This is done by retrospectively and prospectively collecting real life patient data from European registers.

The collaboration promotes opportunities to identify unmet needs in the treatment of SpA patients by utilizing high-quality data from existing patient registries.

Our aims are in line with the EMA initiative for patient registries and are consistent with discussions at the EMA workshop “How to make better use of patient registries to collect high-quality data on medicines” held in London on October 28th, 2016 in London.

EuroSpA RCN Scope

Currently the collaboration consists of 17 registries (see map).

There is a recognized openness to include other interested registries and to other parties such as health authorities (EMA and local regulatory bodies) and patient organizations, although the extent of their involvement will need to be further defined.

Acknowledgements

Novartis Pharma AG for supporting the EuroSpA collaboration.
UCB Biopharma SRL for supporting the EuroSpA collaboration.

Registries that contribute data to the collaboration

ARC (Netherlands)

ATTRA (Czech Republic)

BIOBADASER (Spain)

Biorx.si (Slovenia)

BSRBR-AS/BSR-PsA (United Kingdom)

DANBIO (Denmark)

ERSBTR (Estonia)

GISEA (Italy)

ICEBIO (Iceland)

NOR-DMARD (Norway)

RABBIT-SpA (Germany)

Reuma.pt (Portugal)

ROBFIN (Finland)

RRBR (Romania)

SCQM (Switzerland)

SRQ (Sweden)

TURKBIO (Turkey)

The most recent EuroSpA publications

EuroSpA publication D8.2

By |November 5th, 2024|Categories: News|

Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European  rheumatology registries Click here to [...]

Comments Off on EuroSpA publication D8.2

EuroSpA publication BX.2

By |October 29th, 2024|Categories: News|

Validation of SPARCC MRI-RETIC e-tools for increasing scoring proficiency of MRI sacroiliac joint lesions in axial spondyloarthritis Click here to access full [...]

Comments Off on EuroSpA publication BX.2

EuroSpA publication BX.1

By |October 29th, 2024|Categories: News|

Effect of Online Training on the Reliability of Assessing Sacroiliac Joint Radiographs in Axial Spondyloarthritis: A Randomized, Controlled Study Click here to [...]

Comments Off on EuroSpA publication BX.1

EuroSpA publication 4.3

By |August 20th, 2024|Categories: News|

Comparing DAPSA, DAPSA28, and DAS28-CRP in PatientsWith Psoriatic Arthritis Initiating a First Tumor NecrosisFactor Inhibitor Across Nine European Countries Click here to [...]

Comments Off on EuroSpA publication 4.3

To see full list, please click Publications in top menu

EuroSpA Research Collaboration Network explained by chairpersons Professor Merete Lund Hetland and Professor Mikkel Østergaard
Why is it meaningful to be a part of EuroSpA? – an interview with 8 members of the Scientific Committee

EuroSpA meetings

EuroSpA Scientific Committee consists of representatives from the 17 participating registries, who meets for hybrid meetings twice yearly in Copenhagen and online.

Go to Top